Free CE/CME Activities

Browse free continuing education activities across medical specialties

Une Vision d’Espoir: Lighting the Way in GA Management & TreatmentFree CE/CME

Une Vision d’Espoir: Lighting the Way in GA Management & Treatment

Ophthalmology, Optometry

Available through August 18, 2027

SriniVas R. Sadda, MD, FARVO; Hong-Uyen Hua, MD; Adrienne W. Scott, MD, FASRS

CME
Integrating Motivational Interviewing Techniques to Overcome Barriers to the Use of a Long-Acting Injectable Agent in Patients With SchizophreniaFree CE/CME

Integrating Motivational Interviewing Techniques to Overcome Barriers to the Use of a Long-Acting Injectable Agent in Patients With Schizophrenia

Psychiatry

Available through August 18, 2027

Gerald Maguire, MD; Jacob Hanaie, PharmD, APh, BCPP; Charles Nguyen, MD, DFAPA

CMENCPD
Expert Illustrations & Commentaries™: The Science of Extended DurabilityFree CE/CME

Expert Illustrations & Commentaries™: The Science of Extended Durability

Ophthalmology

Available through August 15, 2027

Talia Kaden, MD; Diana Do, MD

CME
Expert Illustrations & Commentaries™: Outlining the Role of BTK inhibitors in Multiple SclerosisFree CE/CME

Expert Illustrations & Commentaries™: Outlining the Role of BTK inhibitors in Multiple Sclerosis

Neurology

Available through August 1, 2027

Stephen Krieger, MD, FAAN; Enrique Alvarez, MD, PhD

CME
Clinical Consultations: Comprehensive Management of Obesity as a Chronic Disease: New and Emerging StrategiesFree CE/CME

Clinical Consultations: Comprehensive Management of Obesity as a Chronic Disease: New and Emerging Strategies

Endocrinology, Diabetes & Metabolism, Primary Care

Available through August 1, 2027

Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FAMWA, FTOS; Robert Busch, MD

CMENCPD
Rapid Reviews in Retina™: 2026 Bimonthly Updates: Part Two — SafetyFree CE/CME
Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your PracticeFree CE/CME

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Ophthalmology, Optometry

Available through September 5, 2026

Judy E. Kim, MD, FARVO, FASRS; Anat Loewenstein, MD, MHA; Deepak Sambhara, MD, FASRS

CME
Clinical Crossroads™: The Importance of Considering Lambert-Eaton Myasthenic Syndrome (LEMS) in the Differential DiagnosisFree CE/CME
From Chair to Care Plan—Applying Evidence to Patient-Centered ManagementFree CE/CME

From Chair to Care Plan—Applying Evidence to Patient-Centered Management

Ophthalmology, Optometry

Available through July 1, 2027

Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO

CMECOPE
Timing Is Everything—Onset, Duration, and Dosing in Real-World CareFree CE/CME

Timing Is Everything—Onset, Duration, and Dosing in Real-World Care

Ophthalmology, Optometry

Available through July 1, 2027

Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO

CMECOPE